LOKELMA: payments to doctors
Payments that named LOKELMA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $14M
- Providers
- 31,668
- Transactions
- 123,956
- Average per transaction
- $113
The per-transaction average — $113 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 31,668 providers the average total is $442, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $13,961,816 | 99.7% |
| Astrazeneca UK Limited | $28,622 | 0.2% |
| Astrazeneca AB | $8,059 | 0.1% |
| Acerta Pharma LLC | $2,030 | 0.0% |